Research on the importance of nutritional status on outcomes in cystic fibrosis has established a strong association between the two. In this session, we will explore the current state of infant feeding practices. The role of pancreatic enzyme replacement therapy on nutritional status in early childhood and on health care utilization will also be explored. Monitoring of nutritional status has been centered around attaining an optimal BMI, but over-reliance on this measure may lead to missed opportunities. These topics will inform development of nutritional intervention algorithms designed to improve nutritional status.
Compare 1. Compare choice of feeding method for infants with CF and recommend strategies to support optimal growth.
Manage 2. Manage pancreatic enzyme replacement therapy dosing to maximize growth and improve overall health status.
Criticize 3. Critique the effectiveness of BMI to identify nutritionally at-risk patients, and implement a strategy to identify at-risk patients to enter into a nutritional intervention algorithm.
Assistant Clinical Professor,
University of California San Francisco